Skip to content
Lower risk Drug recall · FDA · Published January 28, 2021

Accord Healthcare Glycopyrrolate Injection Recall: Label Mix-Up Risk

Accord Healthcare recalls 25x2mL Glycopyrrolate injection vials due to label mix-up with 1mL vials. Correctly labeled vials were packaged into blister strips intended for 1mL vials.

🇺🇸 FDA recall #D-0250-2021DrugAccord Healthcare ›
Take action

Contact the company

Recalling firmAccord Healthcare, Inc.1009 Slater Rd Ste 210B · Durham, NC 27703-8446
✎ GovInfoNow plain-language explainer

What happened, in plain English

Accord Healthcare is recalling glycopyrrolate injection vials because they were incorrectly packaged with labels meant for 1mL vials instead of the actual 2mL vials. This mix-up could lead to incorrect dosing if the vials are used without checking the label carefully. Read more at govinfonow.com/recall/36540-accord-healthcare-glycopyrrolate-injection-recall-label-mix-up-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/36540-accord-healthcare-glycopyrrolate-injection-recall-label-mix-up-risk · Updated October 4, 2026 · FDA enforcement record: FDA #D-0250-2021

Cite this page

“Accord Healthcare Glycopyrrolate Injection Recall: Label Mix-Up Risk.” GovInfoNow, updated October 4, 2026. https://govinfonow.com/recall/36540-accord-healthcare-glycopyrrolate-injection-recall-label-mix-up-risk. Based on FDA recall #D-0250-2021 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0250-2021%22&limit=1).

Why it’s dangerous

The vials are correctly labeled as 2mL but were packaged into blister strips designed for 1mL vials. This labeling error could cause confusion about the correct dosage if the vials are not checked carefully before use.

Who’s affected

Prescribers and healthcare facilities that use this injection for medical purposes. Patients receiving the medication under a doctor's supervision are most at risk if they use the vials without verifying the label.

How to tell if you have this one

Look for vials labeled 'Glycopyrrolate Injection, USP 0.4 mg/2 mL (0.2 mg/mL) 25 x 2 mL Single Dose Vials Rx Only' with NDC 16729-472-08 (vial NDC 16729-472-30) manufactured by Intas Pharmaceuticals Limited, India.

  • Brand
    Accord Healthcare
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Label Carefully

    Verify the vial label matches the actual 2mL size before use to avoid potential dosing errors.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 12 months after the firm started it.

1. Firm started the recall: Jan 28, 202112. FDA classified it Class III: Feb 8, 202123. Published in FDA’s Enforcement Report: Feb 17, 202134. FDA terminated the recall: Feb 8, 2022420212022
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Other Accord Healthcare recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0250-2021 (January 28, 2021) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0250-2021 to see it in context.
  • Plain-language summary written by qwen3:4b on October 4, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA